Results 101 to 110 of about 109,995 (172)

Comparison of deep prostate-specific antigen response in Black patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or enzalutamide

open access: yesJournal of Comparative Effectiveness Research
Aim: There is limited real-world evidence about prostate-specific antigen (PSA) response to androgen receptor pathway inhibitor treatment in Black patientswithmetastatic castration-sensitive prostate cancer (mCSPC).
Benjamin H Lowentritt   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy